| Literature DB >> 25150363 |
Anna French1, Jane Y Suh2, Carol Y Suh3, Lee Rubin4, Richard Barker5, Kim Bure6, Brock Reeve7, David A Brindley8.
Abstract
The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.Keywords: cell therapies; regenerative medicine; stem cells; strategic partnerships; translation
Mesh:
Year: 2014 PMID: 25150363 DOI: 10.1016/j.tibtech.2014.05.007
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536